T Schott scite author profile

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

T Schott

Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers

Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B

HBsAg-Verlust während Nukleos(tid)-Analoga (NA) und Peg-Interferon-alpha (PEG-IFN) Behandlung ist anhand einer frühen Änderung in der Zusammensetzung des Hepatitis-B-Virus (HBV) Oberflächenantigens (HBsAg) vorhersagbar

Loss of the middle hepatitis B virus (HBV) surface antigen (MHBs) during interferon-alpha (PEG-IFN) treatment is associated with subsequent lower HBV replication in patients with chronic HBeAg negative hepatitis B

Dem Verlust des Oberflächenantigens (HBsAg) des Hepatitis-B-Virus (HBV) während antiviraler Behandlung mit Tenofovir Disoproxil Fumarat (TDF) geht eine Änderung der Zusammensetzung des HBsAg voraus

The distribution of surface antigen (HBsAg) components can distinguish between inactive carriers and active forms of Hepatitis B virus (HBV) infections

HBsAg loss during treatment with nucleo(s)tide analogues is preceded by changes of the composition of the hepatitis B virus surface antigen (HBsAg)

Contact Info

Product

Resources

About